RALEIGH, N.C.--(BUSINESS WIRE)--NephroGenex, Inc. (Nasdaq:NRX), a pharmaceutical company focused on the development of therapeutics to treat kidney disease, will report its fourth quarter and full year 2015 financial results on Wednesday, February 24 after the U.S. financial markets close. The Company will host a conference call and webcast the following day, Thursday, February 25 at 8:30 a.m. EST, to review the financial results and provide an update on its PIONEER program for diabetic nephropathy and upcoming milestones.
